Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) – Equities researchers at William Blair issued their FY2026 earnings per share (EPS) estimates for shares of Ryan Specialty in a report released on Thursday, January 23rd. William Blair analyst A. Klauber expects that the company will post earnings per share of $2.69 for the year. The consensus estimate for Ryan Specialty’s current full-year earnings is $1.82 per share.
Other equities research analysts have also issued reports about the stock. Bank of America upped their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a report on Thursday, October 10th. Barclays raised their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. Keefe, Bruyette & Woods decreased their price target on Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating for the company in a report on Friday, January 10th. Wells Fargo & Company lowered their price objective on Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 14th. Finally, The Goldman Sachs Group lifted their target price on shares of Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a report on Wednesday, October 9th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $74.40.
Ryan Specialty Stock Up 0.4 %
RYAN stock opened at $65.61 on Monday. The company has a market capitalization of $17.18 billion, a P/E ratio of 85.20, a price-to-earnings-growth ratio of 1.14 and a beta of 0.72. Ryan Specialty has a 12 month low of $42.21 and a 12 month high of $75.97. The firm’s fifty day simple moving average is $67.14 and its 200-day simple moving average is $66.40. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.
Ryan Specialty (NYSE:RYAN – Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The firm had revenue of $604.69 million during the quarter, compared to analysts’ expectations of $602.04 million. During the same period last year, the business posted $0.32 earnings per share. The company’s revenue for the quarter was up 20.5% compared to the same quarter last year.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in RYAN. Vanguard Personalized Indexing Management LLC acquired a new position in Ryan Specialty in the second quarter valued at about $248,000. Thrivent Financial for Lutherans lifted its holdings in shares of Ryan Specialty by 519.6% in the 2nd quarter. Thrivent Financial for Lutherans now owns 28,803 shares of the company’s stock worth $1,668,000 after acquiring an additional 24,154 shares during the last quarter. ProShare Advisors LLC purchased a new position in shares of Ryan Specialty during the 2nd quarter worth approximately $280,000. AQR Capital Management LLC acquired a new stake in Ryan Specialty in the 2nd quarter valued at approximately $261,000. Finally, The Manufacturers Life Insurance Company raised its position in Ryan Specialty by 295.1% in the second quarter. The Manufacturers Life Insurance Company now owns 92,718 shares of the company’s stock valued at $5,369,000 after purchasing an additional 69,253 shares during the period. 84.82% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Ryan Specialty
In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the stock in a transaction that occurred on Monday, January 27th. The stock was sold at an average price of $65.25, for a total value of $2,283,750.00. Following the completion of the sale, the director now owns 6,209 shares of the company’s stock, valued at approximately $405,137.25. This trade represents a 84.93 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director David P. Bolger sold 7,055 shares of the company’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total value of $500,058.40. Following the completion of the sale, the director now owns 78,149 shares of the company’s stock, valued at approximately $5,539,201.12. The trade was a 8.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 306,887 shares of company stock valued at $20,402,023 over the last 90 days. Corporate insiders own 11.10% of the company’s stock.
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
See Also
- Five stocks we like better than Ryan Specialty
- What is Forex and How Does it Work?
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- What Does the Future Hold for Eli Lilly?
- What is a Low P/E Ratio and What Does it Tell Investors?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.